Moderate riskFDA DeviceClass II

Biomerieux VITEK 2 AST-N447 kits recalled for false resistance risk

Biomerieux is recalling one lot of VITEK 2 AST-N447 test kits, product reference 424620, because the kits may give false resistant results for carbapenem and/or cephalosporin antibiotics when pouch foil is fractured. The affected lot includes 45,900 cards distributed to Belgium and the Netherlands, and the product is not registered in the US (outside the US only). No injuries have been reported.

From the FDA notice · Read the official notice ↗ · All bioMérieux recalls

What to do

  1. Stop using kits from lot 0853293604 (UDI-DI 03573026634551) and set aside any remaining cards from that lot.
  2. Check whether any pouches show foil fractures, since the risk is linked to kits with fractured pouch foil.
  3. The notice does not specify a remedy; contact Biomerieux for instructions on the affected lot.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
VITEK 2 AST-N447 TEST KIT Product reference 424620
Sold in
Nationwide
Made for
All ages (0 months and older)

Details

Units affected
45,900 cards
Illnesses reported
None reported
Manufactured in
595 Anglum Rd, N/A, Hazelwood, MO, United States
Classification
Class II
Recall number
Z-2715-2026

In the FDA's words

Description
VITEK 2 AST-N447 TEST KIT Product reference 424620 Potential for false resistant carbapenem and/or cephalosporin results when analyzing samples with kits from affected lot that have pouch foil fractures. Lot 0853293604 UDI-DI 03573026634551 Product is not registered in the US. OUS only. Distribution: International distribution to the countries of Belgium and the Netherlands. Affected quantity: 45,900 cards
Hazard
Potential for false resistant carbapenem and/or cephalosporin results when analyzing samples with kits from affected lot that have pouch foil fractures.

More from bioMérieux

See all

Related topics

OtherSterilityMedical devicesSold nationwideMore from FDA Device